We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Zimmer Biomet Holdings Inc (ZBH) Com Stk USD0.01

Sell:$121.29 Buy:$121.31 Change: $1.71 (1.39%)
Market closed |  Prices as at close on 3 December 2021 | Switch to live prices |
Change: $1.71 (1.39%)
Market closed |  Prices as at close on 3 December 2021 | Switch to live prices |
Change: $1.71 (1.39%)
Market closed |  Prices as at close on 3 December 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas and Global Businesses, consisting principally of the United States and other North, Central and South American markets; Europe, Middle East and Africa (EMEA), consisting principally of France, Germany, Italy, Spain and the United Kingdom, and Asia Pacific, consisting primarily of Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong and Malaysia.

Contact details

345 E Main St
United States
+1 (574) 2676131

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$25.03 billion
Shares in issue:
208.91 million
Health Care Equipment
New York Stock Exchange
United States
US dollar

Key personnel

  • Bryan Hanson
    Chairman of the Board, President, Chief Executive Officer
  • Suketu Upadhyay
    Chief Financial Officer, Executive Vice President
  • Wilfred Van Zuilen
    President - Europe, Middle East and Africa
  • Sang Yi
    President, Asia Pacific
  • Ivan Tornos
    Chief Operating Officer
  • Chad Phipps
    Senior Vice President, General Counsel, Secretary
  • Keri Mattox
    Senior Vice President, Investor Relations, Chief Communications Officer
  • Rachel Ellingson
    Senior Vice President, Chief Strategy Officer, Executive Officer
  • Ellison Humphrey
    Senior Vice President, Chief Transformation Officer
  • Nitin Goyal
    Chief Science, Technology and Innovation Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.